EPIVIDIAN

Serial Number 85624595
Registration 4316032
800

Registration Progress

Application Filed
May 14, 2012
Under Examination
Approved for Publication
Jan 22, 2013
Published for Opposition
Jan 22, 2013
Registered
Apr 9, 2013

Trademark Image

EPIVIDIAN

Basic Information

Serial Number
85624595
Registration Number
4316032
Filing Date
May 14, 2012
Registration Date
April 9, 2013
Published for Opposition
January 22, 2013
Renewal Date
April 9, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
800
Status Date
Oct 3, 2023
Registration
Registered
Classes
035 042

Rights Holder

Epividian, Inc.

03
Address
4505 Emperor Blvd, #220
Durham, NC 27703

Ownership History

Epividian, Inc.

Original Applicant
03
Research Triangle Park, NC

Epividian, Inc.

Owner at Publication
03
Research Triangle Park, NC

Epividian, Inc.

Original Registrant
03
Durham, NC

Legal Representation

Attorney
Philip J. Cardinale

USPTO Deadlines

Next Deadline
2656 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20130409)
Due Date
April 09, 2033
Grace Period Ends
October 09, 2033

Application History

34 events
Date Code Type Description Documents
Oct 3, 2023 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Oct 3, 2023 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Oct 3, 2023 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Oct 2, 2023 EROP I TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Loading...
Sep 29, 2023 PR89 O POST REGISTRATION ACTION MAILED - SEC. 8 & 9 Loading...
Sep 21, 2023 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jun 20, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jun 20, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 20, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 20, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 15, 2023 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Apr 9, 2022 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
May 18, 2019 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
May 18, 2019 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
May 18, 2019 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Apr 8, 2019 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Feb 1, 2019 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 9, 2018 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Apr 9, 2013 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 22, 2013 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 22, 2013 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 2, 2013 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 14, 2012 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Dec 9, 2012 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 19, 2012 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 19, 2012 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 16, 2012 ALIE A ASSIGNED TO LIE Loading...
Nov 6, 2012 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 12, 2012 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 12, 2012 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 12, 2012 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 5, 2012 DOCK D ASSIGNED TO EXAMINER Loading...
May 18, 2012 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 17, 2012 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
conducting market research via a proprietary database in the medical research field
First Use Anywhere: May 6, 2012
First Use in Commerce: May 6, 2012
Class 042
contract medical research services for others via a proprietary database, namely, conducting pharmacovigilence studies, clinical outcomes assessment, clinical trial protocol feasibility assessment, and clinical trial candidate identification and selection; pharmaceutical information services, namely, clinical data reporting on adverse event reporting systems for pharmaceutical companies; cloud computing featuring software for use by the pharmacovigilance departments of pharmaceutical companies in adverse event management and adverse event signal detection and tracking; providing cloud-based data warehousing and temporary use of non-downloadable software for clinical data reporting and business intelligence for medical records for medical practices and hospital clinics
First Use Anywhere: May 6, 2012
First Use in Commerce: May 6, 2012

Classification

International Classes
035 042